What CSR means for the world of health

Nathalie Gimenes () and Marielle Audrey Payaud ()
Additional contact information
Marielle Audrey Payaud: MAGELLAN - Laboratoire de Recherche Magellan - UJML - Université Jean Moulin - Lyon 3 - Université de Lyon - Institut d'Administration des Entreprises (IAE) - Lyon

Post-Print from HAL

Abstract: This article proposes a new Corporate Social Responsibility (CSR) framework allowing the evaluation of responsible behaviors and practices in a specific industry. Considering the CSR as a negotiated order in ongoing construction, the partnership between the private and public parties can become a solution in the general interest. The implementation of these partnerships along the value chain enables CSR to be placed as a business opportunity that could develop the strategic potential of the company. The evaluation framework provides an objective view. We are going to mobilize this through an exploratory study filled with qualitative data obtained through websites and CSR reports from 2013 of the ten biggest multinational pharmaceutical industries, proving the know-how of this sector in the field of industrial durability.

Keywords: CSR; evaluation framework; exploratory study; pharmaceutical industry (search for similar items in EconPapers)
Date: 2015-10-08
References: Add references at CitEc
Citations:

Published in 4th International Conference on Social Responsibility, Ethics and Sustainable Business, Georgiana Grigore, Oct 2015, athens, Greece

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01217939

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().